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SUMMARY
Regular distribution of ivermectin reduces onchocerciasis transmission and morbidity by killing, within humans, the
microﬁlarial stage of the parasite (microﬁlaricidal eﬀect). In addition, ivermectin exerts a so-called embryostatic eﬀect by
which microﬁlarial production by the adult female worm becomes suppressed during a number of weeks after treatment.
To assess the overall eﬀect of ivermectin on onchocerciasis transmission and evaluate the likelihood of local elimination of
the infection it is important to estimate the magnitude of the anti-fertility eﬀect over the course of a treatment programme.
Estimates of the eﬀect of repeated drug treatments on the production of microﬁlariae by adult Onchocerca volvulus were
obtained by developing a model that was ﬁtted to data collected from three hyperendemic communities in Guatemala,
where eligible residents received ivermectin twice per year for two and a half years. The data consist of microﬁlarial load
measurements in the skin, collected just before each six-monthly treatment during the programme. The model that is
developed describes the dynamics of an individual host’s expected microﬁlarial load over the 30-month study period. We
adopt a Bayesian approach and useMarkov chainMonte Carlo (McMC) techniques to ﬁt the model to the data. Combining
estimates from the three villages, average microﬁlarial production in the ﬁrst six months post-treatment was reduced by
y64% of its pre-treatment level, regardless of values chosen for the pre-ivermectin fertility rate within plausible ranges.
Increased adult worm death rate after treatment (to mimic removal of macroﬁlariae via nodulectomy during the pro-
gramme) resulted in a smaller estimated magnitude of the embryostatic eﬀect (rate of microﬁlarial production was reduced
by y58% of pre-ivermectin value). After subsequent treatments, the rate of microﬁlarial production appeared to be
similarly decreased. The data and analyses therefore do not support the hypothesis of a cumulative eﬀect of multiple
ivermectin treatments on microﬁlarial production by female worms.
Key words: Onchocerca volvulus, microﬁlariae, multiple ivermectin treatments, Bayesian hierarchical model, Guatemala.
INTRODUCTION
Mass administration with the microﬁlaricidal drug
ivermectin (Mectizan) has been a cornerstone for
onchocerciasis control for the last two decades, since
it was licensed for human use in the late 1980s and
donated for as long as necessary to eliminate the
burden of onchocerciasis by Merck & Co. (Meredith
and Dull, 1998). In the Onchocerciasis Control
Programme in West Africa (OCP), ivermectin was
initially used in conjunction with vector control in
some areas and as a sole control measure in others
(Molyneux and Davies, 1997). In the African Pro-
gramme for Onchocerciasis Control (APOC), oper-
ational in those countries not covered by the OCP,
and in the Onchocerciasis Elimination Program
for the Americas (OEPA), control relies mainly on
the long-term and regular treatment of endemic
populations with ivermectin (annually in APOC and
biannually in OEPA; Richards et al. (2001)), with a
few focal vector elimination projects in APOC.
Regular treatment with ivermectin reduces the
microﬁlarial load in the skin of infected individuals.
This leads to substantial reductions in morbidity,
transmission of the parasite to vectors, and eventu-
ally of the force of infection (see Basa´n˜ez et al. (2006)
for a recent review). Within 14 days of treatment,
microﬁlarial loads are typically reduced to 1% of pre-
treatment levels (Diallo et al. 1986).
In addition to a microﬁlaricidal eﬀect, treatment
with ivermectin exerts a so-called embryostatic
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eﬀect, by which the production of live microﬁlariae
by adult Onchocerca volvulus female worms is in-
hibited for several weeks and occurs at a reduced rate
during subsequent months (Duke, Zea-Flores and
Mun˜oz, 1991). Basa´n˜ez et al. (2008) have conducted a
systematic review and mathematical modelling of
meta-analysed data both for the microﬁlaricidal and
embryostatic eﬀects of single-dose ivermectin, and
their results agreed with those of Plaisier et al. (1995)
who found that about 10–12 months after treatment
microﬁlarial production would have recovered only
toy65–70% of its initial value. However, the ques-
tion still remains as to whether or not this eﬀect is
cumulative, i.e. whether subsequent ivermectin
treatments lead to further reductions in microﬁlarial
production (Kla¨ger et al. 1993). The assumption that
rates of microﬁlarial production are progressively
reduced with each treatment round has been central
to the predictions, derived from the microsimulation
ONCHOSIM model that onchocerciasis can be
eliminated from African settings with the sole use of
ivermectin as a control measure (Winnen et al. 2002).
Since OEPA is an elimination and not only a mor-
bidity reduction programme, and since treatment is
administered twice per year instead of annually in
Latin American settings, we set out to investigate the
anti-fertility eﬀect of multiple doses of ivermectin
administered during a ﬁeld trial in Central America
(Collins et al. 1992). In this trial, the residents of ﬁve
hyperendemic communities (coﬀee ﬁncas) in the
central onchocerciasis focus of Guatemala received
ivermectin every 6 months for 30 months for a total
of ﬁve treatment rounds.
To estimate rates of microﬁlarial production we
develop a model for the dynamics of expected micro-
ﬁlarial load byway of amodel for wormburden during
the 30-month study period. The model incorporates
both the death of adult worms as well as parasite
transmission. To ﬁt the model to data, we adopt a
hierarchical Bayesian approach using Markov chain
Monte Carlo (McMC) to simulate from the posterior
distribution of parameters. This work follows on from
that of Plaisier et al. (1995) who examined rates of
microﬁlarial production by ﬁtting a mathematical
model to data obtained during a ﬁeld trial conducted
in the Asubende region of Ghana, where ﬁve iver-
mectin treatment rounds were administered annually
during a 60-month study period (Alley et al. 1994).
MODELS AND METHODS
Study area and parasitological procedures
We use data on microﬁlarial loads recorded by
Collins et al. (1992) from three coﬀee ﬁncas (namely,
Los Tarrales, Santa Emilia and Los Andes) located
in the vicinity of Lake Atitla´n, in the central oncho-
cerciasis focus of Guatemala. The original study
comprised ﬁve hyperendemic villages (microﬁlarial
prevalence o60%), including also El Vesubio and
Santa Isabel. In our analysis, we excluded data
from the latter two communities because of the
small population size in El Vesubio, and the low
compliance to skin-snipping and treatment in Santa
Isabel. Also, El Vesubio received placebo during the
ﬁrst three treatments, and ivermectin only during the
last two rounds (Collins et al. 1992).
Five ivermectin treatment rounds were adminis-
tered to the eligible population of these communities
at six-month intervals between May 1988 and May
1990. Two skin-snips were taken to measure micro-
ﬁlarial burden immediately prior to each treatment
round: one from the left shoulder, and the other
from the left iliac crest. A 2.0 mm corneoscleral
punch was used to obtain the samples, and they were
subsequently incubated for 24 h in physiological
saline. Skin-snip processing and weighing, and
microﬁlarial counts were done following themethods
of Brandling-Bennett et al. (1981). On the occasion of
each parasitological examination, subcutaneous nod-
ules (onchocercomata) were palpated and recorded
on a body chart for each individual. Since at the time
of the original study the only accepted form of
treatment was excision of detectable nodules, nod-
ulectomy was oﬀered to the participants on a voluntary
basis and undertaken by nodulectomy brigades,
sometimes weeks or months after skin-snipping and
treatment. In fact, after the second treatment round,
skin-snipping and ivermectin were disassociated
from nodulectomy in order to increase compliance
(Collins et al. 1992). We do have nodulectomy data
on the subjects that volunteered for the time period
of the study but the excised nodules were not
analysed for their worm content. Therefore, we lack
individual host data on the precise number of adult
worms actually removed. However, since it is bio-
logically reasonable to suppose that removal of
nodules would cause some degree of excess adult
worm mortality, its possible eﬀects were accounted
for by assessing the sensitivity of model outputs to
variation in the per macroﬁlaria (adult worm) death
rate (see sensitivity analysis section).
On average, treatment coverage of the census
population was 67.1% in Los Tarrales, 61.1% in
Santa Emilia, and 75.5% in Los Andes. In our
analysis we used data only from individuals who
received treatment at all ﬁve timepoints (N=267 in
Los Tarrales, N=119 in Santa Emilia, and N=124
in Los Andes). Further details of the epidemiologi-
cal, parasitological, and entomological characteristics
of these ﬁncas, and of the methods employed during
the surveys can be found in Collins et al. (1992) and
Cupp et al. (1992).
A deterministic model of mean worm burden
The following deterministic model describes the
evolution of mean worm burden in a population of
hosts (see Fig. 1).
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We model worm burden in discrete time, with
time steps every six months. The ﬁve treatment
times occur at times t1, …, t5. Between treatments a
proportion, p, of the worms die for reasons unrelated
to treatment. In general we suppose that for t in the
interval (tj, tj+1) there are on average w˜j
(n)(t) adult
worms per host that have survived (n) rounds of
treatment (n=0, …, j). Here n tracks both the
number of treatment rounds and the worm’s age in
multiples of 6 months. Since treatment occasions
correspond to times when microﬁlaridermia was as-
sessed, the model described below enables observed
microﬁlarial load to be linked to unobserved worm
burden, appropriately lagged. Prior to treatment
(t<t1) we set mean worm burden to be constant
so that w˜j
(0)(t)=w˜0 when j<1 (this assumption is
satisﬁed if the distribution of worm burden is at
equilibrium before treatment). After the start of the
treatment programme ( jo1) mean worm burden is
modelled using the following diﬀerence equation
(time-dependence has been omitted to simplify the
notation)
~wj
(0)=Dj
~wj
(n)=p~w(nx1)jx1 (n=1, . . . , j)
(1)
whereDj is the average number of adult worms newly
acquired per host in (tj, tj+1) that survive to the end of
this period, and p is the fraction of established worms
that survive the interval between treatments. The
parameter Dj depends on microﬁlarial loads within
both the treated and untreated host populations,
since microﬁlariae are transmitted to the simuliid
vectors where they develop into stages infective to
humans.
Among treated (+) hosts average microﬁlarial load
per mg of skin, m˜j
+(t), is set to zero at treatment
time tj, i.e. 100% microﬁlaricidal eﬃcacy is assumed.
Subsequently, for t in (tj, tj+1) the change in average
microﬁlarial load is
d ~m+j
dt
=
1
2
Xj
n=0
w(n)~wj
(n)xmm ~m
+
j (2)
where w˜j
(n)/2 is the average number of female worms
per host (assuming a 1 : 1 sex ratio according to
Schulz-Key and Karam (1986)) ; w(n) is the rate of
microﬁlarial production per mated female worm
after n rounds of treatment, and mm is the per capita
death rate of microﬁlariae. We ignore the impact
of human mortality on mean microﬁlarial load as
the study period is short relative to human life-
expectancy.
The solution to eqn 2 is,
~m+j (t)=
1xexmm(txtj)
2mm
Xj
n=0
w(n)~wj
(n): (3)
Fig. 1. A model for the evolution of mean worm burden in the host population. The rate of microﬁlarial production
by an adult worm depends on the number of treatments experienced. The mean number of worms having received
n treatments is denoted by w˜j
(n) and the average worm burden in untreated hosts is w˜j. Treatments occur at six-month
intervals with the ﬁrst treatment at t1. The solid and dotted lines represent mean microﬁlarial loads in treated and
untreated hosts respectively. The solid arrows represent the eﬀect of mean worm burden in treated and untreated hosts
on mean microﬁlarial load, and the dashed arrows relate microﬁlarial load to infection and the establishment of adult
worms after a 12 month maturation period. Thus the average number, Dj, of adult worms newly acquired by a host
during the interval (tj, tj+1) depends on mean microﬁlarial load in the host population 12 months previously in the
period (tjx2, tjx1).
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For untreated (x) hosts we assume that the mean
microﬁlarial load, m˜j
x(t) has reached an equilibrium
so that for this group,
~mxj (t)=w
(0)~wj=2mm (4)
where w˜j is the average worm burden among un-
treated hosts. Since the dynamics of mean worm
burden is the same in the treated and untreated host
populations (assuming no macroﬁlaricidal eﬀect of
ivermectin), we let ~wj=
Pj
n=0 ~wj
(n).
For the host population as a whole (both treated
and untreated hosts) the average microﬁlarial load
during (tj, tj+1) is
~mj(t)=fj ~m+j (t)+(1xfj)~m
x
j (t) (5)
where fj is the fraction of hosts treated at the jth
treatment. Prior to treatment ( j<1) by deﬁnition.
fj=0. For jo1 we use treatment coverages of the
total, census populations, as reported in Collins et al.
(1992) for each treatment round and within each
community.
Transmission of the parasite between hosts
occurs via the bites of blackﬂy (Diptera: Simuliidae)
vectors. In Guatemala, Simulium ochraceum Walker
s.l. is the main blackﬂy species responsible for
transmission (Collins, 1979). We chose not to model
this process explicitly for the purposes of this paper.
Instead, we note that the life-expectancy of the
vectors and of the larvae within them are short rela-
tive to that of microﬁlariae and adult worms within
humans, and assume that transmission between hosts
occurs instantaneously. Such an assumption has also
been made in other models of ﬁlariases transmission
(Duerr, Dietz and Eichner, 2005).
Following infection of humans, the L3 infective
larvae mature to become adult worms; this is incor-
porated into the model through a time delay. In
particular, the rate at which worms are newly ac-
quired, encapsulated by the parameterDj, is assumed
to depend on average microﬁlarial loads in the
population of hosts 12 months earlier (Duke, 1980)
during the period (tjx2, tjx1). (The sensitivity of
model outcomes to varying incubation periods of
6, 12, and 18 months was low when explored for
an earlier version of the model.) Thus we use the
following expression for Dj
Dj=
Z tjx1
tjx2
q~mjx2(t)e
xmw(tjx1xt)dt (6)
where q is the product of the per microﬁlaria rate
of transmission from one human to another human
(via the vector) and the probability that an inoculated
L3 larva survives the process of maturation within
the human host. Note that the rate of human to
human transmission itself depends proportionally
on the following: (1) the ratio of vectors to humans;
(2) the square of the biting rate per ﬂy on humans;
(3) the probability of establishment of microﬁlariae
within vectors and of L3 larvae within humans, and
(4) the life-expectancy of parasites within surviving
vectors. In reality, q is likely to be density-dependent
(Collins et al. 1977; Basa´n˜ez et al. 1995, 2002, 2007;
Duerr et al. 2003), but we ignore this complexity
in the modelling approach presented here and ex-
pound on its implications in the Discussion. The
term exmw(tjx1xt) represents the probability that a
worm newly acquired at time t survives to tjx1 (mw is
the per capita death rate of worms).
Combining eqns 3–6, we obtain
Dj=
q(1xfjx2)
2mmmw
(1xexmws)w(0)~wjx2
+
q fjx2
2mm
(1xexmws)
mw
x
(exmwsxexmms)
mmxmw
 
r
Xjx2
n=0
w(n)~w(n)jx2
(7)
where s=(tjx1xtjx2).
For j<3 eqn 7 simpliﬁes to become
Dj=
q(1xexmws)w(0)~w0
2mmmw
:
When j<3, we must have that w˜0=Dj+pw˜0 since
we are assuming that mean worm burden is con-
stant prior to treatment. It therefore follows that
Dj=(1xexmws)~w0 and q=2mmmw/w(0) for j<1.
For jo1, the parameter q is unlikely to remain
constant since it will almost certainly depend on the
level of worm burden and the density of various
parasite life-stages. However, we will assume that
changes in worm burdens are suﬃciently small dur-
ing the 30-month study period so that we may set
q=2mmmw/w(0) for j=1, …, 5.
Expected microﬁlarial load within an individual host
The model of the previous section can be extended
to describe the expected dynamics of worm burden
and microﬁlarial load within individual hosts. (In
the context of the analysis presented in this paper the
term ‘expectation’ or ‘expected value’ refers to the
mean or average value of the random variable in
question.) In the following description, the dynamics
of mean worm burden and microﬁlarial load within
the host mimic the dynamics of mean worm burden
across the population of hosts, except that we allow
each host to have a diﬀerent initial worm burden
(w0). By extending the model to the individual, it can
be ﬁtted to individual-level data on microﬁlarial
loads.
Let wj
(n)(t) denote the expected number of worms
within a host at time t in the interval (tj, tj+1) that
have survived (n) rounds of treatment and set
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w0
(0)=w0, prior to treatment (t<t1). Following treat-
ment ( jo1) we have
w
(0)
j =Dj
w
(n)
j =pw
(nx1)
jx1 (n=1, . . . , j)
(8)
where p is the fraction of worms surviving the
interval between treatments and Dj is the average
number of adult worms newly acquired per host in
(tj, tj+1) that survive to the end of this period. The
parameter, Dj, is deﬁned by the model for mean
worm burden of the previous section.
We use the model of the previous section for the
dynamics of mean microﬁlarial load per mg skin in
the host population to describe the expected micro-
ﬁlarial load per mg skin within an individual host,
except that we replace the initial mean worm burden
(w˜0) with the initial worm burden of the individual
(w0). To obtain the expected microﬁlarial load of
a skin snip sample, we multiply by the combined
weight of the two skin-snips that were taken from
each individual.
Speciﬁcally, for the skin-snip sample taken im-
mediately prior to treatment j at the end of the in-
terval (tjx1, tj) the expected microﬁlarial load for an
individual with initial worm burden w0 is mjx1
+ (tj)dj,
where dj is the combined weight of the two skin snips
and
m+jx1(tj)=
w(0)w0=(2mm) j=1
1xexmm (tjxtjx1)
2mm
Pjx1
n=0 w
(n)w
(n)
jx1 j >1
(
: (9)
Observed microﬁlarial loads
Up to this point the model has been deterministic,
i.e. conditional upon an initial worm burden and set
of parameters it provides the expected microﬁlarial
load for the skin snip sample. To model observed
microﬁlarial load we introduce a stochastic element
which arises from the distribution of microﬁlariae
within a host’s skin. For randomly distributed
microﬁlariae, a Poisson distribution would be ap-
propriate. However, it is likely that there is ‘clump-
ing’ of microﬁlariae in the skin (Kershaw, Duke and
Budden, 1954), leading to an excess of zeros in
comparison with the Poisson distribution (Grenfell
et al. 1990; Pion et al. 2006). We have chosen to
model the observed distribution of microﬁlariae with
a zero-inﬂated Poisson distribution. Mechanistically
this distribution may be thought of in terms of
selecting a skin-snip sample from a ‘clumped’ versus
an ‘unclumped’ area (note that this interpretation is
slightly artiﬁcial since we have for simplicity com-
bined data from two skin snips). Within ‘clumped’
areas we assume that the distribution of an in-
dividual’s microﬁlarial load at time tj is Poisson with
probability mass function f(x) and mean djmjx1
+ (tj).
If the probability of selecting from an ‘unclumped’
area is p, then the probability mass function for
observed microﬁlarial load, x, is p+(1xp) f(x) when
x=0 and (1xp)f(x) for x>0.
Model ﬁtting
Estimates were obtained for a restricted set of par-
ameters (Table 1) using a hierarchical Bayesian ap-
proach. These include, for each village, the mean
worm burden per host prior to treatment and the per
female worm rate of microﬁlarial production per mg
of skin after n treatments. For some parameters,
estimation was unnecessary since their values were
known, i.e. skin-snip weights – recorded for each
individual, and fraction of hosts treated at each round
and village – given in Table 1 of Collins et al. (1992).
It was necessary to ﬁx other parameters to improve
the identiﬁability of the model, i.e. to estimate the
parameters from the data with acceptable precision
(Huang, 2005). Fixed parameters were: the death
rates of microﬁlariae and of adult worms, and
pre-treatment rate of microﬁlarial production by
female worms – taken from Table 2 of Basa´n˜ez
and Boussinesq (1999). The parameters for pre-
treatment worm distribution and the zero-inﬂation
parameter, p, of the microﬁlarial distribution were
also estimated for each village.
The hierarchical Bayesian approach involved
estimating parameters associated with the distri-
bution of initial worm burdens. Speciﬁcally, we as-
sumed that the initial worm burdens, w0, are
independent draws from a negative binomial distri-
bution with parameters w˜0 and k representing re-
spectively the mean and degree of overdispersion.
To ensure positive estimates of w(n), w˜0, and k these
parameters were log-transformed, while p was logit-
transformed since it is constrained to be between 0
and 1. The set of transformed parameters, l, is
ln= log (w(n))(n=1, . . . 4) l5=logit (p)
l6= log (~w0) l7= log (k):
It is convenient to form two groups of parameters
lm=(l1, …, l5) and lw=(l6, l7) ; the former are par-
ameters associated with the distribution of micro-
ﬁlarial burden, whereas the latter are parameters that
specify the distribution of initial worm burden in
individuals who took all ﬁve treatments.
Given the initial worm burdens, w0, and par-
ameters lm, the likelihood of the observed micro-
ﬁlarial loads, x, is deﬁned by the zero-inﬂated
Poisson distribution described in the previous section.
The posterior distribution for the transformed
parameters can be expressed in terms of this likeli-
hood p(x|lm,w0), the distribution of initial worm
burdens p(w0|lw), and the prior p(l). Up to a con-
stant of proportionality the posterior distribution is
p(l,w0jx) / p(xjlm,w0)p(w0jlw)p(l): (10)
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We used a prior for p(l) in which the transformed
parameters were assigned independent normal priors
each with standard deviation of 100; for parameters
l1xl4 the mean of the prior was log (0.7), and for
parameters l5, l6 and l7 the means were respectively
logit (0.5), log (50) and log (1). To sample from the
posterior distribution we used the McMC algorithm
described below. The model parameters, deﬁnitions,
and sources are listed in Table 1.
McMC algorithm
Draws were obtained from the posterior distribution
using theGibbs sampler.TheGibbs algorithmworks
by iteratively sampling from the distribution of each
parameter, conditional on the data and on the re-
maining parameters being ﬁxed at their current
values (Gelman et al. 2004). Speciﬁcally, samples
were drawn from p(w0|l, x) and then from p(li|lxi,
w0, x), (i=1, …, 7) where li is the ith parameter and
lxi is the parameter vector, l, excluding the ith
parameter.
The conditional distributions p(w0|l, x) and
p(li|lxi, w0, x) are known up to a constant of
proportionality from eqn 10. Samples were obtained
from p(w0|l, x) using the Adaptive Rejection
Metropolis Sampling (ARMS) algorithm (Gilks,
Best and Tan, 1995), and from p(li|lxi,w0, x) using
the Metropolis algorithm (Metropolis et al. 1953).
The McMC algorithm was programmed using
the R programming language (http://www.r-project.
org), and the ARMS algorithm was implemented
using the arms function from the HI library. The
algorithm used in arms gives real-valued samples,
not integers. To sample from the conditional distri-
bution of initial worm burden p(w0|l, x), the output
of the arms algorithm was rounded and used as the
proposal distribution in a ﬁnal Metropolis step.
The model was ﬁtted separately to data from each
of the three villages. Three sets of simulations
(chains) were produced for each village. We used
microﬁlarial load at treatment 1 multiplied by 2mm/
(w(0)d1) (see eqn 9) as starting values for the initial
worm burden (w0) in all three chains. For the re-
maining parameters diﬀerent starting values were
chosen for each of the three chains. The starting
values were ‘overdispersed’, i.e. they were selected
to be outside the simulated posterior distributions.
Table 1. Parameter/variable deﬁnitions
Parameter/
variable Deﬁnition Value
wj
(n)(t) The number of worms within a host that have
survived n treatments at time t in (tj, tj+1)
w˜j
(n)(t) The average number of worms within the
population of hosts to have received n treatments
m˜j
+(t) Average microﬁlarial load per mg of skin among
treated hosts
m˜j
x(t) Average microﬁlarial load per mg of skin among
untreated hosts
m˜j(t) Average microﬁlarial load per mg skin in the host
population
dj Weight of skin snip sample taken immediately prior
to the jth treatment
fj Fraction of census population treated at treatment j See Table 1#
q Product of the rate of transmission via simuliid
vector and the probability that the L3 larvae
survive maturation within the host
2mmmw/w
(0)
k Overdispersion of the initial distribution of worm
burden
estimated
p Zero-inﬂation parameter of microﬁlarial
distribution
estimated
w˜0 Mean worm burden prior to treatment estimated
w(n) Per female worm rate of microﬁlarial production
per mg of skin after n treatments
estimated
w(0) Per female worm rate of microﬁlarial production
per mg of skin in the absence of treatment
0.7*
mm Per capita death rate of microﬁlariae 0.8*
mw Per capita death rate worms 0.1*
p Proportion of established worms that survive the
interval between treatments
exmw(tj+1xtj)
All rates are per year. Data source * Basa´n˜ez and Boussinesq (1999) #Collins et al.
(1992).
All variables are indexed by treatment number j. Variables wj
(n)(t), w˜j
(n)(t), m˜j
+(t),
m˜j
x(t), m˜j(t) are functions of time t.
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Each chain was run for 2000 iterations. The three
sequences appeared to have converged after 1000
iterations. We treated the ﬁrst half of each chain as
‘burn-in’ and used the second half of each chain to
provide a sample of 3000 on which inference was
based.
Sensitivity analysis
Sensitivity or uncertainty analysis permits explo-
ration of how model outcomes are aﬀected by
changes in structural assumptions (biological hypo-
theses and their mathematical formulation) or
changes in parameter values (Haefner, 1996). To
explore the sensitivity of the results to changes in the
parameter value chosen for w(0) (the pre-treatment
rate of microﬁlarial production) we used the end-
points of the range given in Table 2 of Basa´n˜ez and
Boussinesq (1999) (i.e. w(0)=0.54 and 0.79 yrx1
femalex1 mg of skinx1). In addition the potential
impact of nodulectomy on the results was assessed,
albeit approximately, by performing a sensitivity
analysis in which the death rate of worms post
treatment was increased to mw=0.2 yrx1 (compared
to a pre-treatment value of 0.1 yrx1).
RESULTS
Table 2 presents the estimates for the average rates
of microﬁlarial production corresponding to the
6-month period following each treatment round; the
estimated mean adult worm burden at baseline in
those individuals that took all ﬁve treatments ; the
overdispersion parameter for the initial distribution
of adult worms among hosts, and the zero-inﬂation
parameter for the distribution of microﬁlarial loads.
Each parameter estimate is presented with its as-
sociated 95% Bayesian credible interval. Excluding
the values for treatment 3, the values for the average
rate of microﬁlarial production 6 months after the
previous treatment varied between 0.19 (Santa
Emilia, treatment 1) and 0.36 (Los Tarrales, treat-
ment 2), averaging 0.25 microﬁlariae per mg of skin,
per female worm per year. This represents a re-
duction of 64% from the initial value of 0.7 presented
by Basa´n˜ez and Boussinesq (1999). The values cor-
responding to the third treatment are very low across
the three villages but do not indicate a systematic
downward trend. The values of the mean initial
worm burden per host and overdispersion parameter
among hosts are similar for all three villages aver-
aging to 47 (mean) and 0.35 (overdispersion).
Estimates of the relative change in microﬁlarial
production are robust to changes in the value of w(0).
For both w(0)=0.54 and w(0)=0.79 microﬁlariae
per female worm per year and per mg of skin, the
estimated rate of microﬁlarial production is 37% of
the pre-treatment value (compared to 36% in the
original simulation where w(0)=0.7). By contrast,
increasing the death rate of adult worms post treat-
ment appeared to increase estimates of microﬁlarial
production. Setting mw=0.2 after treatment (pre-
treatment mw=0.1 per year) the estimate of pro-
duction increased to 42% of the pre-treatment value
(i.e. an overall reduction of 58% compared with 64%
for the nominal value). This agrees with intuition,
which suggests that for the same observed micro-
ﬁlaridermia the per worm microﬁlarial production
must be higher if there are fewer adult worms as a
result of nodulectomy (life-expectancy reduced from
10 years to 5 years).
DISCUSSION
Our results (Table 2) show a substantial reduction in
the rate of microﬁlarial production during the six
months after the ﬁrst treatment. On average, the per
capita rate of microﬁlarial production (scaled per mg
of skin) was reduced to y36% of its pre-treatment
(nominal) value of 0.7 microﬁlariae per female per
year. (This pre-treatment value had been estimated
by Basa´n˜ez and Boussinesq (1999) by combining
rates of microﬁlarial release by adult worms main-
tained in vitro (Engelbrecht and Schulz-Key, 1984)
with in vivo estimates presented by Duke (1993).)
However, we did not ﬁnd, unlike Plaisier et al.
(1995), that subsequent treatments reduced cumu-
latively the rate of microﬁlarial production by
O. volvulus.
Estimates of microﬁlarial production were simi-
larly reduced for the six-month periods following
treatments 2 and 4, but were signiﬁcantly lower for
the six months after treatment 3. This pattern was
consistent across the 3 communities. A reduction in
microﬁlarial loads at treatment 3 followed by an in-
crease at treatment 4 had been observed by Collins
Table 2. Parameter estimates with 95% Bayesian credible intervals
Parameter Los Tarrales Santa Emilia Los Andes
w1 0.33 (0.31–0.36) 0.19 (0.17–0.21) 0.24 (0.22–0.26)
w2 0.36 (0.34–0.38) 0.20 (0.18–0.23) 0.24 (0.21–0.27)
w3 0.08 (0.07–0.09) 0.01 (0.00–0.03) 0.07 (0.05–0.08)
w4 0.25 (0.24–0.27) 0.24 (0.21–0.28) 0.21 (0.19–0.24)
w˜0 44 (36–54) 46 (36–64) 51 (38–69)
k 0.38 (0.32–0.44) 0.38 (0.30–0.48) 0.29 (0.23–0.38)
p 0.32 (0.29–0.35) 0.39 (0.33–0.44) 0.42 (0.37–0.46)
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et al. (1992) The low rate of microﬁlarial production
following treatment 3 is diﬃcult to explain biologi-
cally since it does not appear to be part of a systematic
downward trend. A possibility is that this result may
simply reﬂect a change in the way the sample was
collected or analysed at this treatment time. Other
explanations include the possible eﬀects of nod-
ulectomy on worm burden, and the observation that
during the trial transmission of L3 by S. ochraceum
s.l. was substantially reduced (Cupp et al. 1992). The
latter eﬀect, however, is likely to be small since the
reduction in transmission due to treatment is in-
corporated into the model ; furthermore even with
complete interruption of transmission, the adult
worm population would only decline by approxi-
mately 5% per six months (assuming an average life-
expectancy of 10 years for adult worms as in Basa´n˜ez
and Boussinesq (1999) and Plaisier et al. (1991)). A
reduced worm life-expectancy, due to nodulectomy
may be responsible for a larger reduction in the size
of the worm population between treatment 2 and
treatment 3. Furthermore, this reduction in the
size of the worm population may cause a decline in
mating probability and insemination rates which will
in turn further reduce observed microﬁlarial loads.
However, this does not explain the recovery of
microﬁlarial production at treatment 4, unless this is
itself an anomalous result.
The estimated average reduction in microﬁlarial
production 6 months after ivermectin treatment is
consistent with the results of other studies on the
evolution ofmicroﬁlarial load following treatment. In
a study of 5 yearly treatments in Asubende, Ghana,
Plaisier et al. (1995) ﬁtted a model to the data in
which female worms ceased producing microﬁlariae
immediately after treatment, and then gradually
recovered microﬁlarial production with time post-
ivermectin. They estimated that microﬁlarial pro-
duction had reached a value of approximately 68% of
the pre-treatment level 10 months after treatment.
This corresponds to an average rate of microﬁlarial
production during the ﬁrst six months of 20% of
the pre-treatment value assuming microﬁlarial pro-
duction increases linearly during this period.
Duke et al. (1991) found in a longitudinal study
of reproductive activity by O. volvulus after iver-
mectin treatment in Guatemala, that 6 months post-
treatment only 17 out of 53 live females (32%, 95%
CI=0.20, 0.45) were releasing live microﬁlariae.
This ﬁnding is less easy to compare to our result
although the two may be consistent if ivermectin
eliminates microﬁlarial production in a proportion of
worms and has little or no eﬀect in the remaining
worms, as proposed by Plaisier et al. (1995).
Further comparisons are possible by using the
model to predict microﬁlarial loads post treatment.
For a static worm population whose rate of micro-
ﬁlarial production remains at 36% of the pre-
treatment level during the period 6–12 months
following treatment, the expected microﬁlarial load
at 12 months is predicted to be 20% of the pre-
treatment load (from eqns 3 and 4). This ﬁgure is in
agreement with the ﬁndings of a recent meta-analysis
and mathematical model by Basa´n˜ez et al. (2008),
in which average microﬁlarial loads are y20% of
their pre-treatment levels one year after single-dose
ivermectin.
Mean baseline microﬁlarial load was similar across
the villages (Los Tarrales: 27.0 microﬁlariae per mg;
Santa Emilia : 23.5 microﬁlariae per mg, and Los
Andes: 18.6microﬁlariae permg). This is reﬂected in
similar estimates of worm burden among the three
villages, averaging 47 worms per person. Basa´n˜ez
et al. (2002) analyzed data on microﬁlarial loads
collected by Brandling-Bennett et al. (1981), ap-
proximately 10 years earlier than the data used in this
study. They found a higher microﬁlarial load per mg
of skin in Santa Emilia (64.3), but similar loads in
Los Tarrales (18.2) and Los Andes (28.9). This lends
support to the hypothesis of endemic equilibrium
prior to treatment, particularly in the latter two
villages. Although it appears less plausible that Santa
Emilia may have been at endemic equilibrium pre-
ivermectin, this may not signiﬁcantly aﬀect our
results. This is because the analysis undertaken
requires only that mean worm burden should be
approximately constant for the 12 months preceding
the introduction of chemotherapy (the assumed
length of the maturation period from L3 to adult
worm used here). The assumptionmay be reasonable
even if the system is not at endemic equilibrium,
since it is unlikely that adult worm numbers would
have changed considerably within a 12-month
period. Also, mean microﬁlaridermia at the two
timepoints may not be strictly equivalent, as the data
published in 1981 and analysed by Basa´n˜ez et al.
(2002) referred to all the population examined
whereas the data published in 1992 and analysed in
this paper refers to the subset of the population who
adhered to all 5 treatment rounds.
In this study we lacked data on the numbers of
worms removed by nodulectomy from each partici-
pant at each treatment for the reasons mentioned
above; we can therefore not exclude the possibility
that in addition to ivermectin eﬀects, some of the
measured reduction in microﬁlarial load may be due
to nodulectomy (via increased worm mortality).
However, the sensitivity analysis shows that even a
doubling in the rate of worm mortality post iver-
mectin has only a modest eﬀect on the estimate of
worm fertility. It is also reassuring that the estimated
eﬀects are in agreement with those measured in other
studies not confounded by excision of onchocer-
comata (Plaisier et al. 1995; Basa´n˜ez et al. 2008). In
addition to eliminating a potential source of bias,
nodulectomy data would also provide a means of
validating the estimates of mean worm burden using
the relationship between numbers of adult worms
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and excisable (palpable) onchocercomata developed
by Duerr et al. (2001). According to their model
we would expect an average of approximately 10
palpable nodules per person.
Concluding remarks and future directions
One of the strengths of these data is that they may be
used to estimate the eﬀect of successive treatments on
microﬁlarial production by the adult female worms.
This is important in order to further our under-
standing of the long-term impact of ivermectin-
based onchocerciasis control programmes. Our
estimates suggest that the production of microﬁlariae
is not cumulatively reduced by successive ivermectin
treatments over the 30-month study period. How-
ever, this does not rule out the possibility that longer-
term, multiple ivermectin treatments may lead to a
decline in the rate of microﬁlarial production by the
adult worms, or to other changes in the reproductive
biology of the parasite such as female-biased (intra-
nodular) sex ratios, decreased mating probabilities
and insemination rates, and increased macro-
ﬁlaricidal eﬀects (equivalent to irreversible sterilis-
ation of adult worms) (Duke et al. 1991;Gardon et al.
2002; Cupp et al. 2004; Cupp and Cupp, 2005).
The only other model that has been ﬁtted to time-
dependent microﬁlarial data from multiple regular
treatments is that of Plaisier et al. (1995). Although
their modelling approach is diﬀerent from ours,
and the frequency of treatment in Asubende, Ghana
(Alley et al. 1994) was annual rather than 6-monthly
as in Guatemala, the results of both studies are
compatible and also comparable to those obtained by
Basa´n˜ez et al. (2008), who modelled the eﬀect of
a single ivermectin dose. However, Plaisier et al.
(1995) found that a progressive reduction of micro-
ﬁlarial production with each dose would be the
scenario most consistent with the data. It would be
very interesting to reanalyse such data with the
modelling approach presented here, as projections of
onchocerciasis elimination assume operation of such
cumulative eﬀects (Winnen et al. 2002).
In order to extend ourmodel beyond the 30-month
study period with the aim to investigate the prob-
ability of onchocerciasis elimination, we would also
have to acknowledge that q (the per microﬁlaria rate
of success in becoming an established worm) is likely
to be strongly nonlinear, as density dependence has
been identiﬁed to operate upon microﬁlarial uptake
and survival, parasite establishment, vector and
human survival, and the biting rate per ﬂy on humans
(Basa´n˜ez et al. 1995, 1996, 2002, 2007; Duerr et al.
2003; Little et al. 2004).
In conclusion, our ability to project the long-term
impact of ivermectin on transmission and the possi-
bility of infection elimination with microﬁlaricidal
chemotherapy alone depends on improving our
understanding of the eﬀects of repeated treatment on
the population biology of O. volvulus. Modelling
analyses of further time-series of microﬁlarial loads
and/or of the reproductive and viability status of
adult parasites obtained from repeatedly treated
patients (such as the data presented by Gardon et al.
(2002)) will be required to clarify the eﬀect of long-
term ivermectin treatment, and any changes in
treatment eﬃcacy (Osei-Atweneboana et al. 2007)
that may result from chemotherapy-induced selec-
tion pressure acting upon the parasites genome
(Bourguinat et al. 2007, 2008).
The data analysed in this paper were collected during a
study funded by the UNDP/World Bank/WHO Special
Program for Research and Training in Tropical Disease
(project ID870340) conducted in Guatemala between
1988 and 1990. CB would like to thank the Department
of Statistical Science at University College London for
ﬁnancial support provided during the preparation of
this paper. M-GB acknowledges the Medical Research
Council, UK for a Career Establishment Grant.
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